| Several new injectable GLP-1RAs have been approved in different countries since 2017. |
| However, evidence on the comparative effectiveness of these products is absent. |
| The study aimed to examine whether GLP-1RAs have differential efficacy and safety profiles. |
| Not all GLP-1RAs have equal efficacy, but some of the new GLP-1RAs are not inferior to the old ones. |
| The comparative effectiveness profiles should be taken into account when treating patients with type 2 diabetes. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.